{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:31:18Z","timestamp":1791192678075,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.thromres.2013.02.015","type":"journal-article","created":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T00:01:48Z","timestamp":1363392108000},"page":"508-513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["Decreased platelet miR-223 expression is associated with high on-clopidogrel platelet reactivity"],"prefix":"10.1016","volume":"131","author":[{"given":"Rui","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jie","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tie-Min","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2013.02.015_bb0005","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jacc.2012.06.004","volume":"60","author":"Jneid","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2013.02.015_bb0010","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ahj.2010.06.004","article-title":"Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis","volume":"160","author":"Aradi","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2013.02.015_bb0015","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/hrt.2010.220491","article-title":"High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention","volume":"97","author":"Breet","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.thromres.2013.02.015_bb0020","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p-450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2013.02.015_bb0025","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jama.2009.1232","article-title":"Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy","volume":"302","author":"Shuldiner","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2013.02.015_bb0030","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jacc.2008.07.055","article-title":"Calcium-channel blockers reduce the antiplatelet effect of clopidogrel","volume":"52","author":"Siller-Matula","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2013.02.015_bb0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jcin.2010.12.009","article-title":"Clopidogrel and proton pump inhibitors: influence of pharmacological interactions on clinical outcomes and mechanistic explanations","volume":"4","author":"Tantry","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.thromres.2013.02.015_bb0040","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/CIRCULATIONAHA.109.866533","article-title":"Smoking, clopidogrel, and mortality in patients with established cardiovascular disease","volume":"120","author":"Berger","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2013.02.015_bb0045","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jacc.2008.05.054","article-title":"Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel","volume":"52","author":"Ang","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2013.02.015_bb0050","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/eurheartj\/ehr407","article-title":"High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study","volume":"33","author":"Silvain","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.thromres.2013.02.015_bb0055","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/j.1538-7836.2007.02609.x","article-title":"Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events","volume":"5","author":"Bonello","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.02.015_bb0060","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/09537100802272634","article-title":"Reproducibility and standardized reporting of the vasodilator-stimulated phosphoprotein phosphorylation assay","volume":"19","author":"Siller-Matula","year":"2008","journal-title":"Platelets"},{"issue":"562","key":"10.1016\/j.thromres.2013.02.015_bb0065","first-page":"e561","article-title":"Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin","volume":"157","author":"Varenhorst","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2013.02.015_bb0070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1538-7836.2004.01063.x","article-title":"Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases","volume":"3","author":"Aleil","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.02.015_bb0075","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1160\/TH07-05-0324","article-title":"The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis","volume":"98","author":"Blindt","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.02.015_bb0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.thromres.2013.02.015_bb0085","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nature09267","article-title":"Mammalian microRNAs predominantly act to decrease target mRNA levels","volume":"466","author":"Guo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2013.02.015_bb0090","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs","volume":"79","author":"Fabian","year":"2010","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.thromres.2013.02.015_bb0095","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.thromres.2013.02.015_bb0100","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nsmb.1651","article-title":"Existence of a microRNA pathway in anucleate platelets","volume":"16","author":"Landry","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.thromres.2013.02.015_bb0105","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1538-7836.2009.03700.x","article-title":"VAMP8\/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA","volume":"8","author":"Kondkar","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.02.015_bb0110","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.thromres.2013.02.015_bb0115","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1538-7836.2005.01751.x","article-title":"High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome","volume":"4","author":"Cuisset","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.02.015_bb0120","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4244\/51","article-title":"Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Shifting from antiplatelet resistance to bleeding risk assessment?","volume":"5","author":"Cuisset","year":"2009","journal-title":"EuroIntervention"},{"key":"10.1016\/j.thromres.2013.02.015_bb0125","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1182\/blood-2010-09-299719","article-title":"Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity","volume":"117","author":"Nagalla","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.02.015_bb0130","first-page":"219","article-title":"The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease","volume":"1","author":"Sianos","year":"2005","journal-title":"EuroIntervention"},{"key":"10.1016\/j.thromres.2013.02.015_bb0135","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1161\/CIRCULATIONAHA.106.682658","article-title":"Logistic regression","volume":"117","author":"LaValley","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2013.02.015_bb0140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1423-0410.2010.01333.x","article-title":"De novo protein synthesis in mature platelets: a consideration for transfusion medicine","volume":"99","author":"Schubert","year":"2010","journal-title":"Vox Sang"},{"key":"10.1016\/j.thromres.2013.02.015_bb0145","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1538-7836.2011.04414.x","article-title":"Randomized double-blind placebo-controlled crossover study to determine the effects of esomeprazole on inhibition of platelet function by clopidogrel","volume":"9","author":"Fernando","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.02.015_bb0150","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1111\/j.1538-7836.2007.02656.x","article-title":"Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients","volume":"5","author":"Paniccia","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.02.015_bb0155","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev.cellbio.19.110701.155609","article-title":"SNARE protein structure and function","volume":"19","author":"Ungar","year":"2003","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.thromres.2013.02.015_bb0160","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/hrt.2011.227272","article-title":"Association of cytochrome P450 2C19*2 polymorphism with clopidogrel response variability and cardiovascular events in Koreans treated with drug-eluting stents","volume":"98","author":"Oh","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.thromres.2013.02.015_bb0165","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCINTERVENTIONS.111.962555","article-title":"Effect of CYP2C19*2 and *3 loss-of-function alleles on platelet reactivity and adverse clinical events in East Asian acute myocardial infarction survivors treated with clopidogrel and aspirin","volume":"4","author":"Jeong","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.thromres.2013.02.015_bb0170","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jacc.2012.03.056","article-title":"Prospective study on circulating MicroRNAs and risk of myocardial infarction","volume":"60","author":"Zampetaki","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2013.02.015_bb0175","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2011-03-291971","article-title":"MicroRNA function in myeloid biology","volume":"118","author":"O'Connell","year":"2011","journal-title":"Blood"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813000820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813000820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T21:35:35Z","timestamp":1562794535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384813000820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0049384813000820"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2013.02.015","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased platelet miR-223 expression is associated with high on-clopidogrel platelet reactivity","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2013.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}